Axsome Therapeutics. has filed a patent for microparticles containing bupropion, with a particle diameter of 50 µm to 100 µm. These microparticles can be used in pharmaceutical compositions for treating conditions like depression. GlobalData’s report on Axsome Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Axsome Therapeutics Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Axsome Therapeutics, Antibody-conjugate nanoparticles was a key innovation area identified from patents. Axsome Therapeutics's grant share as of January 2024 was 43%. Grant share is based on the ratio of number of grants to total number of patents.

The patent application (Publication Number: US20240000729A1) describes a novel dosage form comprising microparticles containing bupropion hydrochloride and cysteine. The microparticles have specific particle diameter ranges, with at least 80% falling between 1 µm to 300 µm. The patent also specifies the use of laser diffraction for determining particle size, with additional details on the median microparticle diameter and percentiles based on particle diameter.

Furthermore, the patent application extends to a pharmaceutical composition containing bupropion microparticles with similar particle size specifications. The composition includes a sustained release or controlled release polymer and magnesium stearate. The patent emphasizes the importance of the distribution of microparticle sizes, with specific percentiles mentioned for optimal effectiveness. Overall, the patent aims to provide a dosage form and pharmaceutical composition with precise microparticle characteristics for enhanced drug delivery and efficacy.

To know more about GlobalData’s detailed insights on Axsome Therapeutics, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies